Request for Covid-19 Impact Assessment of this Report
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Toxoid in these regions, from 2012 to 2022 (forecast).
United States Toxoid market competition by top manufacturers/players, with Toxoid sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Biocompare
GSK
Zoetis
Sanofi
Merck
...
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Tetanic Toxoid
Diphtheria Toxoid
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Toxoid for each application, including
Hospitals
Clinics
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Toxoid Market Report 2017
1 Toxoid Overview
1.1 Product Overview and Scope of Toxoid
1.2 Classification of Toxoid by Product Category
1.2.1 United States Toxoid Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Toxoid Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Tetanic Toxoid
1.2.4 Diphtheria Toxoid
1.2.5 Others
1.3 United States Toxoid Market by Application/End Users
1.3.1 United States Toxoid Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 United States Toxoid Market by Region
1.4.1 United States Toxoid Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Toxoid Status and Prospect (2012-2022)
1.4.3 Southwest Toxoid Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Toxoid Status and Prospect (2012-2022)
1.4.5 New England Toxoid Status and Prospect (2012-2022)
1.4.6 The South Toxoid Status and Prospect (2012-2022)
1.4.7 The Midwest Toxoid Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Toxoid (2012-2022)
1.5.1 United States Toxoid Sales and Growth Rate (2012-2022)
1.5.2 United States Toxoid Revenue and Growth Rate (2012-2022)
2 United States Toxoid Market Competition by Players/Suppliers
2.1 United States Toxoid Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Toxoid Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Toxoid Average Price by Players/Suppliers (2012-2017)
2.4 United States Toxoid Market Competitive Situation and Trends
2.4.1 United States Toxoid Market Concentration Rate
2.4.2 United States Toxoid Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Toxoid Manufacturing Base Distribution, Sales Area, Product Type
3 United States Toxoid Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Toxoid Sales and Market Share by Region (2012-2017)
3.2 United States Toxoid Revenue and Market Share by Region (2012-2017)
3.3 United States Toxoid Price by Region (2012-2017)
4 United States Toxoid Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Toxoid Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Toxoid Revenue and Market Share by Type (2012-2017)
4.3 United States Toxoid Price by Type (2012-2017)
4.4 United States Toxoid Sales Growth Rate by Type (2012-2017)
5 United States Toxoid Sales (Volume) by Application (2012-2017)
5.1 United States Toxoid Sales and Market Share by Application (2012-2017)
5.2 United States Toxoid Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Toxoid Players/Suppliers Profiles and Sales Data
6.1 Biocompare
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Toxoid Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Biocompare Toxoid Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 GSK
6.2.2 Toxoid Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 GSK Toxoid Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Zoetis
6.3.2 Toxoid Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Zoetis Toxoid Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sanofi
6.4.2 Toxoid Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sanofi Toxoid Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Merck
6.5.2 Toxoid Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merck Toxoid Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
...
7 Toxoid Manufacturing Cost Analysis
7.1 Toxoid Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Toxoid
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Toxoid Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Toxoid Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Toxoid Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Toxoid Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Toxoid Sales Volume Forecast by Type (2017-2022)
11.3 United States Toxoid Sales Volume Forecast by Application (2017-2022)
11.4 United States Toxoid Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Figure Product Picture of Toxoid
Figure United States Toxoid Market Size (K Pcs) by Type (2012-2022)
Figure United States Toxoid Sales Volume Market Share by Type (Product Category) in 2016
Figure Tetanic Toxoid Product Picture
Figure Diphtheria Toxoid Product Picture
Figure Others Product Picture
Figure United States Toxoid Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Toxoid by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Toxoid Market Size (Million USD) by Region (2012-2022)
Figure The West Toxoid Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Toxoid Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Toxoid Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Toxoid Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Toxoid Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Toxoid Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Toxoid Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Toxoid Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Toxoid Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Toxoid Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Toxoid Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Toxoid Sales Share by Players/Suppliers
Figure 2017 United States Toxoid Sales Share by Players/Suppliers
Figure United States Toxoid Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Toxoid Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Toxoid Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Toxoid Revenue Share by Players/Suppliers
Figure 2017 United States Toxoid Revenue Share by Players/Suppliers
Table United States Market Toxoid Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Toxoid Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Toxoid Market Share of Top 3 Players/Suppliers
Figure United States Toxoid Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Toxoid Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Toxoid Product Category
Table United States Toxoid Sales (K Pcs) by Region (2012-2017)
Table United States Toxoid Sales Share by Region (2012-2017)
Figure United States Toxoid Sales Share by Region (2012-2017)
Figure United States Toxoid Sales Market Share by Region in 2016
Table United States Toxoid Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Toxoid Revenue Share by Region (2012-2017)
Figure United States Toxoid Revenue Market Share by Region (2012-2017)
Figure United States Toxoid Revenue Market Share by Region in 2016
Table United States Toxoid Price (USD/Pcs) by Region (2012-2017)
Table United States Toxoid Sales (K Pcs) by Type (2012-2017)
Table United States Toxoid Sales Share by Type (2012-2017)
Figure United States Toxoid Sales Share by Type (2012-2017)
Figure United States Toxoid Sales Market Share by Type in 2016
Table United States Toxoid Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Toxoid Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Toxoid by Type (2012-2017)
Figure Revenue Market Share of Toxoid by Type in 2016
Table United States Toxoid Price (USD/Pcs) by Types (2012-2017)
Figure United States Toxoid Sales Growth Rate by Type (2012-2017)
Table United States Toxoid Sales (K Pcs) by Application (2012-2017)
Table United States Toxoid Sales Market Share by Application (2012-2017)
Figure United States Toxoid Sales Market Share by Application (2012-2017)
Figure United States Toxoid Sales Market Share by Application in 2016
Table United States Toxoid Sales Growth Rate by Application (2012-2017)
Figure United States Toxoid Sales Growth Rate by Application (2012-2017)
Table Biocompare Basic Information List
Table Biocompare Toxoid Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biocompare Toxoid Sales Growth Rate (2012-2017)
Figure Biocompare Toxoid Sales Market Share in United States (2012-2017)
Figure Biocompare Toxoid Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Toxoid Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Toxoid Sales Growth Rate (2012-2017)
Figure GSK Toxoid Sales Market Share in United States (2012-2017)
Figure GSK Toxoid Revenue Market Share in United States (2012-2017)
Table Zoetis Basic Information List
Table Zoetis Toxoid Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Zoetis Toxoid Sales Growth Rate (2012-2017)
Figure Zoetis Toxoid Sales Market Share in United States (2012-2017)
Figure Zoetis Toxoid Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Toxoid Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Toxoid Sales Growth Rate (2012-2017)
Figure Sanofi Toxoid Sales Market Share in United States (2012-2017)
Figure Sanofi Toxoid Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Toxoid Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Toxoid Sales Growth Rate (2012-2017)
Figure Merck Toxoid Sales Market Share in United States (2012-2017)
Figure Merck Toxoid Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Toxoid
Figure Manufacturing Process Analysis of Toxoid
Figure Toxoid Industrial Chain Analysis
Table Raw Materials Sources of Toxoid Major Players/Suppliers in 2016
Table Major Buyers of Toxoid
Table Distributors/Traders List
Figure United States Toxoid Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Toxoid Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Toxoid Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Toxoid Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Toxoid Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Toxoid Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Toxoid Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Toxoid Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Toxoid Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Toxoid Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Toxoid Sales Volume Share Forecast by Region (2017-2022)
Figure United States Toxoid Sales Volume Share Forecast by Region (2017-2022)
Figure United States Toxoid Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...